Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
CRISPR-Cas9 conjugation platform for engineering designer beta cells (RRID:SCR_026072)Copy Citation Copied
URL: https://patents.google.com/patent/US20220162649A1/en
Proper Citation: CRISPR-Cas9 conjugation platform for engineering designer beta cells (RRID:SCR_026072)
Description: This technology relies on newly described chemical modifications that allow site-specific and multiple-site conjugation of a wide assortment of molecules on both the termini and internal sites of Cas9, creating a platform for endowing Cas9 with diverse functions. Using this platform, Cas9 can be modified to more precisely incorporate exogenously supplied single-stranded oligonucleotide donor (ssODN) at the DNA break site. We demonstrate that the multiple-site conjugation of ssODN to Cas9 significantly increases the efficiency of precision genome editing, and such a platform is compatible with ssODNs of diverse lengths.
Resource Type: instrument resource
Defining Citation: PMID:32792475
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for CRISPR-Cas9 conjugation platform for engineering designer beta cells.
No alerts have been found for CRISPR-Cas9 conjugation platform for engineering designer beta cells.
Source: SciCrunch Registry